The BBS Revolution bladder scanner from dBMEDx Inc has received 510(k) clearance from the FDA, which allows the company to market the device. The BBS Revolution is a battery-powered and pole-mounted wireless probe that automatically charges when docked in the console, according to the company. It is intended to offer ease of use, speed, and accuracy for the non-invasive measurement of bladder volume. It performs the image collection and analysis automatically, transferring the results wirelessly to the console or other mobile platforms.
According to the dBMEDx website, the automated bladder volume measurement device is an important component of a comprehensive CAUTI (catheter associated urinary tract infection) prevention program. The BBS Revolution device is said to provide rapid and accurate measurement, a wireless and lightweight probe, minimal user training, built-in instructions, and no aiming required.
“Receiving FDA clearance is a pivotal step as we prepare to launch the BBS Revolution device,” said David Shine, CEO of dBMEDx. “With the recent announcement from Medicare regarding penalties for hospital-acquired conditions, hospitals will be looking for better, more effective tools to fight CAUTI, and the BBS Revolution uniquely answers that need with unparalleled ease of use and accuracy.”
The BBS Revolution will be on view in the dBMEDx booth at the AORN Surgical Conference & Expo in March 2015 and the American Urological Association annual meeting in May.
For more information about the BBS Revolution bladder scanner, visit the dBMEDx website.
